Search research articles
Contact Us
Filters
Showing results (371-380 of 379) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 379 results.
Journal of Viral Hepatitis
|
November 1, 1996
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected]
P Colombatto, A Randone, G Civitico, et al.
Annals of Hematology
|
August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M Witzens-Harig, G Hess, J Atta, et al.
Leukemia
|
October 16, 2019
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia
M Fürstenau, J Bahlo, A M Fink, et al.
Leukemia
|
March 25, 2018
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
S Rule, W Jurczak, M Jerkeman, et al.
Leukemia
|
September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C Buske, E Hoster, M Dreyling, et al.
Science (New York, N.Y.)
|
November 18, 2006
The impact of boreal forest fire on climate warming
J T Randerson, H Liu, M G Flanner, et al.
Leukemia
|
October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach
T Burmeister, J Maurer, M Aivado, et al.
Science (New York, N.Y.)
|
January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent
J Linnen, J Wages, Z Y Zhang-Keck, et al.
Lancet (London, England)
|
October 5, 2010
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M Hallek, K Fischer, G Fingerle-Rowson, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 379) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 379 results.
Journal of Viral Hepatitis
|
November 1, 1996
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected]
P Colombatto, A Randone, G Civitico, et al.
Annals of Hematology
|
August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M Witzens-Harig, G Hess, J Atta, et al.
Leukemia
|
October 16, 2019
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia
M Fürstenau, J Bahlo, A M Fink, et al.
Leukemia
|
March 25, 2018
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
S Rule, W Jurczak, M Jerkeman, et al.
Leukemia
|
September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C Buske, E Hoster, M Dreyling, et al.
Science (New York, N.Y.)
|
November 18, 2006
The impact of boreal forest fire on climate warming
J T Randerson, H Liu, M G Flanner, et al.
Leukemia
|
October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach
T Burmeister, J Maurer, M Aivado, et al.
Science (New York, N.Y.)
|
January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent
J Linnen, J Wages, Z Y Zhang-Keck, et al.
Lancet (London, England)
|
October 5, 2010
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M Hallek, K Fischer, G Fingerle-Rowson, et al.
Page
of 38